Germ-Line Gene Modification and Disease Prevention: Some Medical and Ethical Perspectives
- 22 October 1993
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 262 (5133) , 533-538
- https://doi.org/10.1126/science.8211180
Abstract
There has been considerable debate about the ethics of human germ-line gene modification. As a result of recent advances in the micromanipulation of embryos and the laboratory development of transgenic mice, a lively discussion has begun concerning both the technical feasibility and the ethical acceptability of human germ-line modification for the prevention of serious disease. This article summarizes some of the recent research on germ-line gene modification in animal models. Certain monogenic deficiency diseases that ultimately might be candidates for correction by germ-line intervention are identified. Several of the most frequently considered ethical issues relative to human germ-line gene modification are considered in the context of professional ethics, parental responsibility, and public policy. Finally, it is suggested that there is merit in continuing the discussion about human germ-line intervention, so that this technique can be carefully compared with alternative strategies for preventing genetic disease.Keywords
This publication has 60 references indexed in Scilit:
- Animal models of human genetic diseasesTrends in Genetics, 1993
- Germ-line Gene Therapy: A New Stage of DebateLaw, Medicine and Health Care, 1992
- Lymphoma Regression Induced by Ganciclovir in Mice Bearing a Herpes Thymidine Kinase TransgeneHuman Gene Therapy, 1990
- Tissue-Specific Expression in Transgenic Mice of a Fused Gene Containing RSV Terminal SequencesScience, 1986
- The ethics of human gene therapyNature, 1986
- Partial correction of murine hereditary growth disorder by germ-line incorporation of a new geneNature, 1984
- Biochemical Evidence of Dysfunction of Brain Neurotransmitters in the Lesch-Nyhan SyndromeNew England Journal of Medicine, 1981
- Gene Therapy in Human Beings: When Is It Ethical to Begin?New England Journal of Medicine, 1980
- Mutation and Cancer: Statistical Study of RetinoblastomaProceedings of the National Academy of Sciences, 1971
- Enzyme Defect Associated with a Sex-Linked Human Neurological Disorder and Excessive Purine SynthesisScience, 1967